Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
Sponsor: Jade Biosciences, Inc.
Summary
This is a Phase 1, first in human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE201 compared to placebo in participants with Rheumatoid Arthritis
Official title: A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JADE201 Administered Subcutaneously in Participants With Rheumatoid Arthritis
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2026-05
Completion Date
2028-10
Last Updated
2026-04-21
Healthy Volunteers
No
Conditions
Interventions
JADE201
JADE201 is supplied as sterile solution to be administered by SC injection.
Placebo
Placebo solution to be administered at a matching volume by SC injection.
Locations (3)
Jade Clinical Site
Chisinau, Moldova, Moldova
Jade Clinical Site
Ivano-Frankivsk, Ukraine, Ukraine
Jade Clinical Site
Kyiv, Ukraine, Ukraine